Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
about
The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticlesPeriodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort studyAutoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?Systemic Sclerosis and Malignancy: A Review of Current DataAssociations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociChronic immune stimulation and subsequent Waldenström macroglobulinemiaCurrent understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateMicrotubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative diseasePatients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapyDemyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.Geographic trends and risk of gastrointestinal cancer among patients with celiac disease in Europe and Asian-Pacific regionRisk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.Screening tests using serum tissue transglutaminase IgA may facilitate the identification of undiagnosed celiac disease among Japanese population.Antiviral immune responses: triggers of or triggered by autoimmunity?Abatacept treatment for rheumatoid arthritisThe epidemiology and pathogenesis of neoplasia in the small intestine.Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancerA Case of a Laryngeal MALT Lymphoma in a Patient with a History of Gastric MALT.Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.Oral non-Hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexateA Burkitt's Lymphoma Case Mimicking Crohn's Disease: A Case ReportPrevious Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control StudyA meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.Primary MALT Lymphoma of the Breast Treated with Definitive Radiation.Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use.Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphomaPopulation-based study of autoimmune conditions and the risk of specific lymphoid malignanciesCommon immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.Is there truly a risk of lymphoma from biologic therapies?Autoimmunity and hematologic malignancies: associations and mechanisms.Radiation for MALT of the Submandibular Gland.Development of autoimmunity in lymphoma.Hepatosplenic T-cell lymphoma and inflammatory bowel disease.Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy.Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.Mitochondria and redox homoeostasis as chemotherapeutic targets.
P2860
Q23916045-F4225D9C-EABE-4B78-9DA2-45A737683400Q24645966-20605769-6E36-4534-91B1-7F03391CDE2BQ26739361-B2F314CD-23B0-4DA6-930A-F1B117E76A41Q26740318-B504D811-3ED1-4C24-83C4-A56E5BA81500Q28083556-CAB996E8-60C2-44FD-B1EB-E151CD61C240Q28294893-5D2E23D4-08EB-4EFB-A7E2-7A29BA490AE1Q28388876-53650861-4D4B-4E22-89DF-A069A460A39EQ28591529-70EB475D-CDFB-43BB-BB3A-11E47BD20676Q28651110-5F04AB73-1E37-494F-9AA8-AC172614518DQ31098318-EEBD85ED-C6DD-41BB-8D2C-B67EA89D923CQ33596660-90834C37-DA59-4486-8339-8A5BF3A4AF66Q33734256-F2DEBE0D-5751-4068-A726-189065415268Q33754667-A446AF5C-B304-474D-A840-A9DAA65690E9Q33789445-04488A01-B733-4C05-9D01-263CBC80B996Q34588972-D5477870-CA0A-4BE7-BE97-6C4E9D201ACAQ34601452-46AF912A-CB46-4971-8113-FEFAF0AD3915Q34637366-8DBAB757-A725-415D-95C6-267E866DFED3Q35034042-2C1BD1D7-C301-405C-A329-74C2974835CFQ35164271-E44A92C6-F9A5-425F-B278-BE3BEB133312Q35201455-32E444CA-93C1-41D4-8626-FF7BE10BD372Q35207682-F35FEFAC-59A8-4247-B055-4F0DF084FF91Q35794786-B9FF9398-0795-4CE4-8747-165F69BB4A1EQ36757029-01745017-A4ED-43E3-99EE-633DFE232C12Q36928149-56D6593F-4C4F-4C14-9BA4-B2292FADE44FQ37003547-1F93AAEF-0707-4ECB-A796-DE8A9E7474F0Q37033240-0A617A7B-1765-4309-AAA9-81DF7FDA649AQ37082267-DA114A10-E0F8-41D7-9E1C-DE403783D435Q37218079-8E4C45C8-95E1-4160-82D8-B75BBA2E7DD3Q37325965-68C17869-39B5-4386-AC1F-2E2737B48121Q37383042-EBB82310-A743-41A2-8F14-B6610B8060D3Q37383424-EC7C6164-E35C-4D07-BC4C-3D60EDFA950EQ37400338-0AA8103D-B731-427A-BBAC-04A082C769CEQ37448413-1C355806-8D1C-48FB-B95A-7EBAC9ADAE76Q37598126-973124F1-F872-47B1-A1C1-A1E2B638799EQ37754707-F67DE128-0E3E-4756-91C2-D123DF9C27D2Q37814566-0F5AE131-074D-41F9-85E2-6BD3B3AEB183Q37975303-0809E03B-2B12-4E02-8835-CD1649CBF08CQ38055211-C404A56E-D0A1-4403-B4CB-37DB97F14CBCQ38217806-AA2E3EBF-EC17-40D7-B268-76C593DC85F1Q38238632-D5DB682B-F420-4365-887B-4EBBBB14CBA1
P2860
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@ast
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@en
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@nl
type
label
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@ast
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@en
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@nl
prefLabel
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@ast
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@en
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@nl
P1476
Malignant lymphomas in autoimm ...... and lymphoma characteristics.
@en
P2093
Eva Baecklund
Johan Askling
P304
P356
10.1158/1055-9965.EPI-06-0300
P577
2006-11-01T00:00:00Z